Researchers conducted a retrospective cohort study using data of 411 adults with T2D and obesity (mean age, 48.3 years; 63.3% women; mean BMI, 47.4) who were referred for bariatric surgery to a ...

This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. If you're struggling with weight, you're not alone. Around 42 percent of American adults have obesity. In addition to nutrition, ...

Patients who received GLP-1 RAs had significantly higher rates of diabetes, hyperlipemia, and chronic obstructive pulmonary disease than those who underwent surgery. After 3 years, patients who ...

Sleeve gastrectomy and gastric bypass were associated with about five-times more weight loss than weekly injections of GLP-1 receptor agonists semaglutide or tirzepatide, at the end of two years, ...

Bariatric surgery is more cost-effective and offers better long-term outcomes than GLP-1 RAs for obesity and metabolic comorbidities. GLP-1 RAs face challenges like high costs, limited insurance ...

Isabel Casimiro, MD, PhD, is an endocrinologist at the University of Chicago in Illinois. As a physician-scientist in molecular biology, she uses her research on diabetes, lipid disorders, ...

Combining bariatric surgery with weight loss medication can help people who need to lose more weight post-surgery, Monash University and Alfred Health-led research has found. The paper is published in ...

GLP-1 medications have become game changers for people trying to lose weight, but bariatric surgery is still superior when it comes to total and lasting weight loss, a new study has found. Patients ...

People who begin obesity treatment with glucagon-like peptide-1 receptor agonists (GLP-1s) and then undergo metabolic and bariatric surgery achieve substantially greater weight loss than with the ...

If you're struggling with weight, you're not alone. Around 42 percent of American adults have obesity. In addition to nutrition, exercise and medications, some might explore the idea of weight ...